Long-term efficacy and safety of terazosin in patients with benign prostatic hyperplasia
Author:
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Quantifying the Smooth Muscle Content of the Prostate Using Double-Immunoenzymatic Staining and Color Assisted Image AnalysisJournal of Urology, 1992
- The response to alpha blockade in benign prostatic hyperplasia is related to the percent area density of prostate smooth muscleThe Prostate, 1992
- A Dose Titration Study Evaluating Terazosin, a Selective, Once-a-Day α 1-Blocker for the Treatment of Symptomatic Benign Prostatic HyperplasiaJournal of Urology, 1990
- Efficacy of once-A-day terazosin in benign prostatic hyperplasia: A randomized, double-blind placebo-controlled clinical trialThe Prostate, 1990
- The Alpha Adrenergic Binding Properties of Terazosin in the Human Prostate Adenoma and Canine BrainJournal of Urology, 1988
- Prazosin in the Treatment of Prostatic Obstruction A Placebo‐controlled StudyBritish Journal of Urology, 1987
- Effects of Prazosin in Patients with Benign Prostatic ObstructionJournal of Urology, 1983
- Bladder Outflow Obstruction Treated with PhenoxybenzamineBritish Journal of Urology, 1982
- Light Microscopic Stereological Analysis of the Normal Human Prostate and of Benign Prostatic HyperplasiaJournal of Urology, 1979
- A Placebo‐controlled Double‐blind Study of the Effect of Phenoxybenzamine in Benign Prostatic ObstructionBritish Journal of Urology, 1978